172@29@16@13!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Oct 20, 16:00
5069.35 17.90 (0.35%)
Volume
AVERAGE VOLUME
5-Day
67,226
10-Day
58,581
30-Day
103,266
52,936
  • Prev. Close

    5051.45

  • Open Price

    5100.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 20, 15:59
5071.15 13.00 (0.26%)
Volume
AVERAGE VOLUME
5-Day
2,234,216
10-Day
2,093,385
30-Day
3,690,877
1,380,290
  • Prev. Close

    5058.15

  • Open Price

    5056.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    5071.15 (121)

Financials

2019 2018 2017 2016 2015
Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 2,775.80 1,700.70 697.00 1,544.50 1,580.00  
Net CashFlow From Operating Activities 1,839.20 2,762.10 1,538.60 1,015.90 2,798.20  
Net Cash Used In Investing Activities -1,689.20 -550.90 -1,179.90 1,442.50 -1,961.10  
Net Cash Used From Financing Activities -224.10 -2,223.10 -304.40 -2,581.80 -693.70  
Foreign Exchange Gains / Losses 0.00 4.40 -0.30 -12.00 -9.20  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -74.10 -7.50 54.00 -135.40 134.20  
Cash And Cash Equivalents Begin of Year 113.20 120.70 66.70 202.10 60.00  
Cash And Cash Equivalents End Of Year 39.10 113.20 120.70 66.70 194.20  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs